Literature DB >> 1155068

Post-mortem distribution and tissue concentrations of digoxin in infants and adults.

K E Andersson, A Bertler, G Wettrell.   

Abstract

By means of 86Rb uptake inhibition assay, the distribution and tissue concentrations of digoxin in various tissues during maintenance therapy were studied post mortem in 12 infants (aged 5 days to 8 months) and 17 adults (aged 49-91 years). The mean maintenance dose for infants was 0.014 mg/kg bw/24 h and for adults, 0.005 mg/kg bw/24 h. The same relative distribution of the glycoside found in infants and in adults was: choroid plexus greater than ventricular myocardium greater than kidney greater than liver greater than skeletal muscle. Between infants and adults, the mean digoxin concentrations in choroid plexus, kidney, liver, and skeletal muscle did not differ significantly; however, significant differences were found in the glycoside concentrations in ventricular and in atrial myocardium. Both infants and adults showed a difference in the content of the glycoside within the heart, the concentration in ventricular muscle being significantly higher than in atrial. There seemed to be no direct relation between the tissue concentrations of the glycoside (myocardium, skeletal muscle) and the daily maintenance dose/mg/kg bw/24 h). The results suggest that the myocardial binding of digoxin is higher in infants than in adults.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155068     DOI: 10.1111/j.1651-2227.1975.tb03871.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  15 in total

1.  Absorption of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

2.  Distribution and elimination of digoxin in infants.

Authors:  G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies.

Authors:  J G Kelly; R M McMillen; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  Digoxin dosage schedules for neonates and infants based on pharmacokinetic considerations.

Authors:  L Nyberg; G Wettrell
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  [Plasma digoxin concentration in different age groups (author's transl)].

Authors:  D Lang; R Hofstetter; G von Bernuth
Journal:  Klin Wochenschr       Date:  1978-01-15

10.  Tissues concentration and excretion of deslanatoside C-3H in newborn and growing rabbits.

Authors:  A Marzo; P Ghirardi; G Lorenzi; A Marini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.